United Kingdom· GB-APID-20836411000001109
Biofactor Streptokinase 250,000unit powder for solution for infusion vials
A medicinal product containing streptokinase, registered in United Kingdom by Beacon Pharmaceuticals Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Streptokinase
- Manufacturer
- Beacon Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin0793573976031
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Streptokinase in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/98803304-3b8a-4786-ab70-3f99f1db8cce GET /v1/drugs/98803304-3b8a-4786-ab70-3f99f1db8cce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "20836411000001109",
"desc": "Biofactor Streptokinase 250,000unit powder for solution for infusion vials (Beacon Pharmaceuticals Ltd)",
"form": "Powder for solution for infusion",
"vpid": "39714211000001106",
"source": "dmd",
"vtm_id": "777613005",
"strength": "250000 unit",
"substance": "Streptokinase",
"ingredient": "Streptokinase",
"supplier_code": "3844101000001106"
}See everything about streptokinase.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.